Download PDF
1 / Pages

Other users also viewed these articles

Fenofibrate normalizes alkaline phosphatase and improves long-term outcomes in patients with advanced primary biliary cholangitis refractory to ursodeoxycholic acid Dawei Ding; Pengwei Ren; Guanya Guo; Yansheng Liu; Chunmei Yang; Linhua Zheng; Gui Jia; Juan Deng; Ruiqing Sun; Xiufang Wang; Xinmin Zhou; Yulong Shang; Ying Han;
Gastroenterol Hepatol. 2023;46:692-701
Risk factors for fibrosis progression in non-alcoholic steatohepatitis: Analysis of the European cohort in the real-world GAIN study Anum Shaikh; Gabriel Pedra; Leonardo Ruiz-Casas; Bethany Franks; Harpal Dhillon; João Diogo da Rocha Fernandes; Kamal Kant Mangla; Margarida Augusto; Manuel Romero-Gómez; Jörn M. Schattenberg;
Gastroenterol Hepatol. 2024;47:463-72
Predictive models for hepatocellular carcinoma development after sustained virological response in advanced hepatitis C Miguel Fraile-López; Carmen Alvarez-Navascués; María Luisa González-Diéguez; Valle Cadahía; Valentina Chiminazzo; Andrés Castaño; María Varela; Manuel Rodríguez;
Gastroenterol Hepatol. 2023;46:754-63